ClinicalTrials.gg
CompletedNCT07199803Updated Oct 7, 2026

OBS-QoR-10 in Patients With and Without Postpartum Hemorrhage

An observational study in Postpartum Hemorrhage (Primary), sponsored by Samuel Lunenfeld Research Institute, Mount Sinai Hospital. Completed at 1 site in Canada. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-07.

Sponsored by Samuel Lunenfeld Research Institute, Mount Sinai Hospital · Observational

How we know

Updated Oct 7, 2026Now CompletedPrimary completion moved+4 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
136
Ages
18 Years and older
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 34 studies in Postpartum Hemorrhage by Samuel Lunenfeld Research Institute, Mount Sinai Hospital — 5 open to participants now, 6 under way, none of them phase 3. Postpartum Hemorrhage · Samuel Lunenfeld Research Institute, Mount Sinai Hospital.

Started
2025
with 3 others
Observational
2 of 34
none open now
Registered
34th of 34
by date

Among the 34 studies in Postpartum Hemorrhage by Samuel Lunenfeld Research Institute, Mount Sinai Hospital, this one is one of 4 that started in 2025, is one of 2 observational ones, and was the 34th registered.

Postpartum Hemorrhage

471 studies on the registry are indexed under Postpartum Hemorrhage; 76 are open to participants now.

Browse Postpartum Hemorrhage studies →

Open to participants now

5 of the 34 studies in Postpartum Hemorrhage by Samuel Lunenfeld Research Institute, Mount Sinai Hospital are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 5 open studies →

Where they have run

Who these studies take

Of the 41 Postpartum Hemorrhage studies recruiting now, 21 (51%) set no upper age limit and 20 (49%) stop at 75 or younger; 6 take children under 18; 20 take healthy volunteers.

This study: 18 Years and older · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 34 studies in Postpartum Hemorrhage by Samuel Lunenfeld Research Institute, Mount Sinai Hospital, or all of them as a file.
02

Study summary

Postpartum hemorrhage (PPH) remains a leading cause of maternal death and morbidity. Moreover, it also contributes to psychological trauma such as depression and post-traumatic stress disorder. The American College of Obstetrics and Gynecology (ACOG) and the Society for Maternal Fetal Medicine (SMFM) defines this morbidity as an unintended outcome in the birthing process that may have significant short-term and long-term consequences to an individual's health. A recent study in 2018 developed core outcomes set for PPH through Delphi consensus encompassing elements of prevention and management of PPH.

Patient-reported outcomes, breastfeeding, and overall sense of wellbeing were not included in the final outcome set. Nevertheless, investigators felt strongly that they should be included, but further work was needed to assess the factors influencing the quality of recovery in the context of PPH. This is aligned with increasing recognition that patient experiences are important to improving the quality of care and quality of recovery after Cesarean delivery. The most effective, i.e. validated tool for assessing postpartum recovery is the Obstetric Quality of Recovery-10 (Obs-QoR-10). However its application in patients with PPH remains unexplored. It would appear logical that patient experiencing PPH experience a potentially more challenging recovery process which may include more surgical complications, depressive symptoms, sleep deprivation, physical exhaustion and stress due to unexpected and undesired delivery events. This study aims to compare Obs-QoR-10 scores in patients with and without PPH to evaluate the impact of severe postpartum bleeding on recovery outcomes using a matched case-control design.

The investigators plan to determine the differences in Obs-QoR-10 scores between patients who experience PPH during childbirth and those deliver without PPH, and to evaluate the impact of PPH on specific recovery domains (physical comfort, emotional well-being, and functional recovery).

03

Conditions studied

  • Postpartum Hemorrhage (Primary)

Browse trials for

Keywords

  • cesarean delivery
  • vaginal delivery
  • ObsQoR-10
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Patients that deliver at Mount Sinai Hospital with measured blood loss greater than or equal to 1000ml, and a set of controls matching the following criteria with measured blood loss less than 1000ml:

  • Age (±5 years)
  • Parity (1 or >1)
  • Mode of delivery (vaginal vs. cesarean delivery)
  • Labour (Labouring and Non-labouring cesarean delivery)
  • Urgency (Scheduled vs Unscheduled Cesarean delivery)
  • Gestational age at delivery (± 4 weeks)
  • Delivery date within 2 weeks

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients aged 18 years or older who have delivered at Mount Sinai Hospital.
  • Delivery via vaginal or cesarean delivery with neuraxial analgesia or anesthesia
  • Ability to communicate in English (to answer OBSQoR-10 survey) PPH Cohort

    • Quantitative Blood Loss (QBL) ≥ 1000 mL or,
    • Transfusion of blood due to PPH or,
    • Transfer to ICU level care due to PPH
    • Significant PPH intervention, i.e. hysterectomy or arterial embolization Non-PPH
    • QBL \< 500 mL and,
    • No transfusion of blood products, and
    • No need for elevated care environment, i.e. HAU or ICU

Exclusion criteria

Exclusion Criteria:

  • Patients with pre-existing psychiatric disorders affecting recovery assessment.
  • Patients who experience severe obstetric complications other than PPH (e.g., eclampsia, uterine rupture).
  • Overdistended uterus due to; Polyhydramnios (amniotic fluid index >24 cm) or multiple gestation
  • History of previous PPH (documented with blood loss of >1000 ml, blood transfusion, use surgical methods such as Bakri balloon, B-Lynch sutures, uterine artery ligation or embolization)
  • > 50
  • Language barrier (English)
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
136 participants (actual)
Patient registry
No

Groups and cohorts

  • Vaginal delivery with PPH

    Patients who deliver vaginally with a quantitative blood loss greater than or equal to 1000ml.

    Other: Obstetric Quality of Recovery-10 (ObsQoR-10©) Scoring Tool

  • Vaginal delivery without PPH

    Patients who deliver vaginally with a quantitative blood loss less than 1000ml.

    Other: Obstetric Quality of Recovery-10 (ObsQoR-10©) Scoring Tool

  • Cesarean delivery with PPH

    Patients who deliver vaginally with a quantitative blood loss greater than or equal to 1000ml.

    Other: Obstetric Quality of Recovery-10 (ObsQoR-10©) Scoring Tool

  • Cesarean delivery without PPH

    Patients who deliver vaginally with a quantitative blood loss less than 1000ml.

    Other: Obstetric Quality of Recovery-10 (ObsQoR-10©) Scoring Tool

Interventions

  • OtherObstetric Quality of Recovery-10 (ObsQoR-10©) Scoring Tool

    The ObsQoR-10 tool aims to quantitatively measure functional recovery at 24 hours postpartum. It includes 10 questions on a 0 to 10 scale, aimed at pain management, the adverse effects of narcotics and the perception of recovery by the patient.

06

What researchers measure

Primary outcomes

  1. Obstetric Quality of Recovery-10 (ObsQoR-10) score 24-72 hours

    ObsQoR-10 score between 24 and 72 hours postpartum. There are 10 questions, and the results are tabulated out of 100. The higher the overall score out of 100, the better quality of recovery a patient is experiencing.

    Time frame: 72 hours

Secondary outcomes

  1. Semi-quantitative blood loss total (ml)

    Semi-quantitative blood loss total (ml) as measured postpartum

    Time frame: 1 hour

  2. Length of hospital stay (hours)

    Time from admission to discharge from hospital in hours

    Time frame: 4 days

  3. Additional uterotonic medication administered - questionnaire

    Presence of administration and dosing of any additional uterotonic medication.

    Time frame: 24 hours

  4. Blood transfusion

    Administration of any blood product and amount given.

    Time frame: 48 hours

  5. Surgical interventions for PPH - questionnaire

    Use of any surgical interventions for PPH as documented by the surgical team.

    Time frame: 2 hours

07

Study locations

1 site
  • Mount Sinai Hospital
    Toronto, Ontario M5G1X5, Canada
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Oct 2025 to primary completion in Mar 2026, 5 months.

Of 38 non-industry observational studies under Postpartum Hemorrhage, half reached primary completion within 30 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 39. This study's 5 months is below that.

Counting every sponsor, half of 42 studies reached it within 21 months; a quarter within 9 and three quarters within 38.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 7, 2026: primary completion Jul 2026 → Mar 2026 and completion Jul 2026 → Mar 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Sep 22, 2025
First posted
Sep 30, 2025
StartActual
Oct 3, 2025
Primary completionActual
Mar 10, 2026was Jul 2026
CompletionActual
Mar 13, 2026was Jul 2026
Last update
Oct 7, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Completed
changed Oct 7, 2026
Primary completion
Jul 2026→Mar 10, 2026 (actual)
Oct 7, 2026
Study completion
Jul 2026→Mar 13, 2026 (actual)
Oct 7, 2026
Enrollment
152 (estimated)→136 (actual)
Oct 7, 2026
Eligibility
Revised
Oct 7, 2026
Primary outcomes
1 edited
What changed in the outcomes
  • EditedObstetric Quality of Recovery-10 (ObsQoR-10) score 24-4872 hoursTime frame: 24 hours → 72 hours
Oct 7, 2026
Show all 1 update
  1. Oct 7, 2026
    Recruiting→Completed
    Primary completion Jul 2026→Mar 10, 2026 (now actual)
    Study completion Jul 2026→Mar 13, 2026 (now actual)
    Enrollment 152 (estimated)→136 (actual)
    Eligibility Revised
    Primary outcomes 1 edited
    What changed in the outcomes
    • EditedObstetric Quality of Recovery-10 (ObsQoR-10) score 24-4872 hoursTime frame: 24 hours → 72 hours
    + 3 other changes: verification date, contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07199803
Responsible party
Sponsor
First posted
Sep 30, 2025
Start date
Oct 3, 2025
Primary completion
Mar 10, 2026
Completion
Mar 13, 2026
Last update
Oct 7, 2026

Study contacts

Ronald George, MD
principal investigator · MOUNT SINAI HOSPITAL

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion